Manual
Description
Bacterial endotoxin, lipopolysaccharide (LPS), is a fever-producing by-product of gram-negative bacteria commonly known as pyrogen. LPS consists of a polysaccharide, a core oligosaccharide and lipid A, which is responsible for the toxic effects. In human, lipopolysaccharide binding protein (LBP) plays a central role in response to LPS in the activation pathway and in the neutralization of LPS.
Removal of endotoxin is one of the most difficult downstream processes during protein purification. EndoTrap® blue, as part of the EndoClear kit, is developed to meet the most challenging requirements of endotoxin removal: the highest endotoxin removal capacity combined with excellent recovery rates. EndoTrap® blue is based on affinity chromatography for column or batch mode. The working range of EndoTrap® blue is pH 4-9 and it works with an ionic strength up to 600 mM NaCl. Proteins, peptides, antibodies and plasmid DNA can be applied onto the EndoTrap® blue column. Customer specific buffers can be used when enriched freshly with Ca2+.
Besides the EndoTrap® blue, EndoTrap® red is also available. EndoTrap® red has a pH range of 6-9 and is capable to work with an ionic strength up to 250 mM ( <100 mM is recommended). LPS from Klebsiella pneumoniae and Serratia marcescens can only be removed with EndoTrap® red.
The detection of endotoxin is based on studies of Frederick Bang. He observed that bacteria caused intravascular coagulation in the American horseshoe crab, Limulus polyphemus. In collaboration, Levin and Bang found that the agent responsible for the clotting phenomena resided in the crab's amoebocytes, or circulating blood cells, and that pyrogen triggers the turbidity and gel-forming reaction enzymatically.
The Mini-LAL assay for endotoxin detection, the second part of the EndoClear kit, makes use of an activated enzyme. In the presence of a colorless substrate, the enzymatic reaction will cause a yellow colour to develop upon cleavage of the chromophore, p-nitroaniline (pNA). The reaction is stopped by the addition of acetic acid and the absorbance at 405 nm is measured with a spectrophotometer. The endotoxin concentration of samples with unknown concentrations, which are run concurrently with the standards, can be determined from a standard curve
Application
The EndoClear kit provides the opportunity to remove and detect endotoxin with just one kit. EndoClear consists of the Profos EndoTrap® blue assay (endotoxin removal) and the Hycult Biotech Mini-LAL assay (endotoxin detection).
The Profos EndoTrap® blue assay is intended for the removal of endotoxin with removal rates of >95% per cycle. The binding capacity of EndoTrap® blue is 2,000,000 EU/ml (1EU = 100 pg LPS)
The Hycult Biotech Mini-LAL assay is intended for the quantitative detection of endotoxin in culture medium, buffers, and other solutions. The kit has a minimum endotoxin detection limit of 0.01 EU/ml and a measurable concentration range of 0.01 to 10 EU/ml.
Features
Profos EndoTrap® blue assay (endotoxin removal):
- Binding capacity of 2,000,000 EU/ml.
- Endotoxin removal rates of >95% per cycle.
- Final LPS concentration 0.005 - 0.1 EU/ml.
- Column or batch mode.
- Operating at pH 4.0-9.0.
- Suitable for plasmid DNA, proteins, peptides and antibodies.
- Suitable for an ionic strength up to 600 mM NaCl.
- Customer specific buffers can be used when enriched freshly with Ca2+.
Hycult Biotech Mini-LAL assay (endotoxin detection):
- Minimum concentration which can be measured is 0.01 EU/ml.
- Measurable endotoxin detection range of 0.01-10 EU/ml.
- Working volume of 50 µl/well.
- 72 determinations
- Operating at pH 6.5-8.0.
Typical standard curve
Principle
Profos EndoTrap® blue assay (endotoxin removal):
- The Profos EndoTrap® blue Assay is based on affinity chromatography with a working time of ~30 minutes.
- Sample is applied to the column with equilibration buffer.
- Fractions are collected.
- Endotoxin removal rate is >95% per cycle.
- Samples are measured with Hycult Biotech LAL Assay.
Hycult Biotech Mini-LAL assay (endotoxin detection):
- The LAL assay is an enzyme-based assay with a working time of ~45 minutes.
- Samples and standards are incubated with LAL reagent.
- The enzymatic reaction, triggered by endotoxin, will cause a yellow color to develop upon cleavage of the chromophore, p-nitroaniline.
- The enzymatic reaction is stopped by the addition of acetic acid.
- The absorbance at 405 nm is measured with a spectrophotometer. A standard curve is obtained by plotting the absorbance (linear) versus the corresponding concentrations of the E. coli standards (log).
- The endotoxin concentration of samples, which are run concurrently with the standards, can be determined from the standard curve.
Storage and stability
Products should be stored at 2 - 8 °C. Under recommended storage conditions, products are stable for at least six months.
The Profos EndoTrap® blue columns should be stored in regeneration buffer with 0.02% sodium azide.
After reconstitution the Hycult Biotech Mini-LAL assay reagents (
E. coli standard and LAL reagent) should be stored in aliquots at -20 °C.
Recovery
Recovery for the Hycult Biotech Mini-LAL assay is evaluated by interference (inhibition/enhancement) testing through spiking a sample or diluted sample with a known concentration of endotoxin and testing for spike recovery in duplicate following the assay procedure. In general, serum samples contain interfering factors. Therefore, we recommend to perform recovery experiments to confirm the reliability of endotoxin detection in serum. For interference testing select a point at or near the middle of the standard curve. The calculated mean amount of endotoxin in the spiked sample, when referenced to the standard curve, must be within 50-200% to be considered free of inhibition or enhancement. Failure to recover the spike within 50-200% indicates sample interference. Further dilute the sample in endotoxin free water until the spike is recovered consistently by the assay.
References
- Gonçalves, S et al; Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transpl 2006, 21: 2788
- Bowdish, D et al; The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J Immunol 2004, 172: 3758
- Bublin, M et al; Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses. Vaccine 2007, 25: 8395
- Cordery, D et al; Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue. J Infect Dis 2007, 195: 905
Precautions
For research use only. Not for use in or on humans or animals or for diagnostics. It is the responsibility of the user to comply with all local/state and Federal rules in the use of this product. Hycult Biotech is not responsible for any patent infringements that might result with the use or derivation of this product.
All materials coming in contact with specimen or test material should be endotoxin-free.
Also available